|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Cancernext Genetic Panel
Test CodeCANCERNEXT PANEL(AMBRY)
Includes
Genes on this panel include APC, ATM, BARD1, BRCA1, BRCA2, BRIP1, BMPR1A, CDH1, CDK4, CDKN2A, CHEK2, EPCAM, GREM1, MLH1, MRE11A, MSH2, MSH6, MUTYH, NBN, NF1, PALB2, PMS2, POLD1, POLE, PTEN, RAD50, RAD51C, RAD51D, SMAD4, SMARCA4, STK11, and TP53.
Full gene sequencing is performed for 30 of the genes (excluding EPCAM and GREM1). Gross deletion/duplication analysis is performed for all 32 genes.
Full gene sequencing is performed for 30 of the genes (excluding EPCAM and GREM1). Gross deletion/duplication analysis is performed for all 32 genes.
Preferred Specimen
3 whole blood lavender EDTA
Minimum Volume
6-10 mL
Transport Temperature
Room temperature
Methodology
Next Generation Sequencing (NGS)
Report Available
2-4 weeks
Reference Range
Provided with the patient report in CPRS.
Performing Laboratory
Test performed at Ambry Genetics and transported via Quest.
Additional Information
Link to test information on Ambry Genetics website
Last Updated: January 24, 2019